Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02392286 · ClinicalTrials.gov registry record · Phase 4
Corticosteroid Dosage for Crohn's Disease Flare
A Phase 4 study, sponsored by Yale University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
NCT02392286 is a Phase 4 study that was terminated before completion, run by Yale University. The registered enrollment target is 15 participants.
The verdict
NCT02392286, a Phase 4 study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
Study Summary
Prospective randomized comparative effectiveness trial designed to compare fixed dosing and weight-based dosing of corticosteroids in patients with Crohn's disease flares.
Interventions
- DRUG Corticosteroid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-12-19 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02392286
The ClinicalTrials.gov registry entry for NCT02392286 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Corticosteroid is the first listed.
NCT02392286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02392286 about?
NCT02392286 is a clinical study titled "Corticosteroid Dosage for Crohn's Disease Flare". Prospective randomized comparative effectiveness trial designed to compare fixed dosing and weight-based dosing of corticosteroids in patients with Crohn's disease flares.
What is the current status of trial NCT02392286?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2015-03. Estimated completion is 2016-12-19.
What interventions are being tested in trial NCT02392286?
The interventions under investigation include: Corticosteroid (DRUG).
Who is sponsoring clinical trial NCT02392286?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.